Clinical practice guidelines for the treatment of lung cancer

From Cancer Guidelines Wiki


Clinical practice guidelines for the treatment of lung cancer

Contents

Foreword

Summary of recommendations (Printable version)

Non small-cell lung cancer

Stage I operable

Surgery

Radiotherapy

Chemotherapy

Stage I inoperable

Surgery

Radiotherapy

Chemotherapy


Stage II operable

Surgery

Radiotherapy

Chemotherapy

Stage II inoperable

Radiotherapy

Chemotherapy


Stage III operable

Surgery

Radiotherapy

Chemotherapy

Stage III inoperable

Single and multimodality therapies


Stage IV operable

Surgery

Radiotherapy


Stage IV inoperable

Radiotherapy

Chemotherapy

Small cell lung cancer

Limited stage

Chemotherapy

Radiotherapy

Extensive stage

Chemotherapy

Radiotherapy


Palliative care

Supportive care

Questions under development

  • What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?
  • What is the role of immunotherapy in “unselected” patients with stage IV NSCLC?
  • What is the role of immunotherapy in selected patients by PDL1 staining percentage in tumours (by immunohistochemistry)?
  • What is the optimal systemic therapy regimen in selected patients for treatment of stage IV inoperable NSCLC?

Appendices


Further information for health professionals

Investigating symptoms of lung cancer: a guide for GPs

Information for consumers

Understanding Lung Cancer

General comments

Please provide general comments regarding this guideline by using the comment button below.